EC ever use among women of reproductive age: 5.8% (ENADID 2009)
EC knowledge among women of reproductive age: 75.8% (ENADID 2009)
Contraceptive Use: 63.9%, ENADID 2009, ever use of a modern method among women of reproductive age
Registered LNG-EC products:
- Alterna - Available directly from pharmacist without prescription (i.e. BTC)
- Dreams - Available directly from pharmacist without prescription (i.e. BTC)
- Glanique - Available directly from pharmacist without prescription (i.e. BTC)
- Ladiades 0.75 - Available directly from pharmacist without prescription (i.e. BTC)
- Ladiades 1.5 - Available directly from pharmacist without prescription (i.e. BTC)
- Oportuna - Available directly from pharmacist without prescription (i.e. BTC)
- PostDay - Available directly from pharmacist without prescription (i.e. BTC)
- Postinor-2* - Available directly from pharmacist without prescription (i.e. BTC)
- Postinor-2 Unidosis* - Available directly from pharmacist without prescription (i.e. BTC)
- Prudence for Her - Available directly from pharmacist without prescription (i.e. BTC)
- Silogin 0.75mg - Available directly from pharmacist without prescription (i.e. BTC)
- Silogin 1.5mg - Available directly from pharmacist without prescription (i.e. BTC)
- Vika* - Available directly from pharmacist without prescription (i.e. BTC)
Registered UPA-EC products:
- ellaOne* - Available only with prescription
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Public sector clinics, Pharmacies, IPPF-affiliated system
Age restrictions for accessing ECPs: No
Legal/regulatory documents in which EC is included: National FP Norms, National GBV Norms, Essential Medicines List
Pricing information: EC is available in the public health system free of charge, mainly in family planning centers.
Other relevant information: EC is also available through health centers and services attending female victims of rape.
In 2012, a total of 6.8 million doses of EC were sold in Mexico (IMS data).
EC distributed via IPPF outlets (10,000 - 20,000 in 2012).
For more information, see below: